Resource Hub

From Prescription
to Persistence: Sustaining GLP-1 Therapy Over Time

How Mighty, the AI health assistant within MyTherapy’s DTP ecosystem, protects GLP-1 persistence at predictable risk moments.

Smartpatient and Novo Nordisk Set a New Standard for Connected Care for People with Metabolic Diseases in Germany

A new Type 2 diabetes support program from smartpatient and Novo Nordisk expands their shared Direct-to-Patient model across metabolic diseases. Continuous, personalized support designed for where long-term treatment habits are formed.

Smartpatient and Daiichi Sankyo Join Forces to Improve Treatment Adherence in Hypercholesterolemia

MyTherapy now provides dedicated digital support for patients treated with Nustendi®, helping them stay adherent and reduce their cardiovascular risk.

Direct-to-Patient Marketing in Pharma: How DTC Pharma Campaigns Drive Better Treatment Uptake

Smartpatient and ALK Celebrate Three Years Driving Long-Term Allergy Treatment Persistence

Through behavioral science and digital engagement, the partnership supports thousands of allergy patients across Europe stay consistent with allergy immunotherapy and achieve lasting outcomes.